Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-11-17
2010-12-14
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S253010, C514S253100, C514S254040, C544S238000, C544S360000, C544S364000, C544S367000
Reexamination Certificate
active
07851473
ABSTRACT:
There is provided a FAAH inhibitor and a prophylactic or therapeutic agent for cerebrovascular disorders or sleep disorders comprising it. The prophylactic or therapeutic agent comprises a compound of the formula (I0):wherein Z is oxygen or sulfur; R1is aryl which may be substituted, or a heterocyclic group which may be substituted; R1ais a hydrogen atom, a hydrocarbon group which may be substituted, hydroxyl, etc.; R2is piperidin-1,4-diyl which may be substituted, or piperazin-1,4-diyl which may be substituted; R3is a group formed by eliminating two hydrogen atoms from a 5-membered aromatic heterocyclic group having 1 to 3 heteroatoms selected from nitrogen, oxygen and sulfur, which may be further substituted, —CO—, etc.; and R4is a hydrocarbon group which may be substituted, or a heterocyclic group which may be substituted; or a salt thereof.
REFERENCES:
patent: 6525059 (2003-02-01), Anantanarayan et al.
patent: 2003/0092734 (2003-05-01), Boger
patent: 2004/0006091 (2004-01-01), Kyle et al.
patent: 2006/0089344 (2006-04-01), Abouabdellah et al.
patent: 2006/0173184 (2006-08-01), Apodaca et al.
patent: 2007/0004741 (2007-01-01), Apodaca et al.
patent: 2854633 (2004-11-01), None
patent: 9903870 (2000-05-01), None
patent: WO 99/16751 (1999-04-01), None
patent: WO 99/19303 (1999-04-01), None
patent: WO 99/32121 (1999-07-01), None
patent: WO 01/44201 (2001-06-01), None
patent: WO 02/062963 (2002-08-01), None
patent: WO 02/087569 (2002-11-01), None
patent: WO 03/039440 (2003-05-01), None
patent: WO 03/051797 (2003-06-01), None
patent: WO 03/065989 (2003-08-01), None
patent: WO 03/103669 (2003-12-01), None
patent: WO 2004018439 (2004-03-01), None
patent: WO 2005/070910 (2005-08-01), None
patent: WO 2005/090347 (2005-09-01), None
patent: WO 2006/088075 (2006-08-01), None
Kenneth et al., Synthesis and evaluation of Pyridazinylpiperazines as vanilloid receptor 1 antagonists; Bioorganic & Medicinal Chemistry Letters (2004), 14(22), 5513-5519.
International Search Report for International Publication No. PCT/JP2005/021136 dated Feb. 14, 2006.
Kathuria et al., “Modulation of anxiety through blockade of anandamide hydrolysis” Nature of Medicine. vol. 9. No. 1 pp. 81 Jan. 2003.
Registry (STN Files) [online], Registry No. 681136-29-8 Registry, Entered STN: May 11, 2001. Chemical Library (Supplier: Maybridge plc) [retrieval date Feb. 1, 2006], internet, <URL: https://stnweb-japan.cas.org/>.
Registry (STN Files) [online], Registry No. 681136-27-6 Registry, Entered STN: May 11, 2001. Chemical Library (Supplier: Maybridge plc) [retrieval date Feb. 1, 2006], internet, <URL: https://stnweb-japan.cas.org/>.
Registry (STN Files) [online], Registry No. 606088-64-6 Registry, Entered STN: May 11, 2001. Chemical Library (Supplier: Maybridge plc) [retrieval date Feb. 1, 2006], internet, <URL: https://stnweb-japan.cas.org/>.
Registry (STN Files) [online], Registry No. 606088-85-01 Registry, Entered STN: May 11, 2001. Chemical Library (Supplier: Maybridge plc) [retrieval date Feb. 1, 2006], internet, <URL: https://stnweb-japan.cas.org/>.
Database Registry [Online], Chemical Abstracts Service, Columbus, Ohio, US; May 11, 2004, XP002538499, retrieved from STN, Database accession No. 681136-26-5.
Kiyota Yoshihiro
Kori Masakuni
Matsumoto Takahiro
Miyazaki Jun-ichi
Hamre Schumann Mueller & Larson P.C.
Sackey Ebenezer
Takeda Pharmaceutical Company Limited
Wilson James O
LandOfFree
Amide compound does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amide compound, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amide compound will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4185984